The global next generation sequencing (NGS) market is expected to register a robust CAGR of around 15% over the next five years. This growth is primarily driven by the rising adoption of precision ...

New methods of testing tissue and plasma beyond next-generation sequencing (NGS) could be used to deliver the best ...

For managed care organizations and health systems, the recommendations strongly advocated highly selective use of NGS. Routine, nonselective NGS for all sarcoma patients is not justified. Instead, ...

Countable Labs has launched Countable 10, a PCR instrument capable of detecting 10 distinct fluorophores within a single reaction.

In modern retail logistics, where distribution centers support omnichannel fulfillment strategies, the complexity of outbound ...

Swiss Rockets, MGI US LLC and Complete Genomics Inc. announced today that they entered into a exclusive license agreement ...

Across conversations on precision oncology, malignant hematology, cellular therapies, and social determinants of health (SDOH ...

ESMO 2025 showcased the breadth and urgency of breast cancer research, which remains one of the most diagnosed malignancies ...

The United States Tumor Profiling Market is projected to surge from US$ 3.41 billion in 2024 to US$ 7.44 billion by 2033, ...

ETH Zurich scientists have created “MetaGraph,” a revolutionary DNA search engine that functions like Google for genetic data. By compressing global genomic datasets by a factor of 300, it allows ...

Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”), a clinical-stage leader in regenerative and cellular innovation, today announced the official launch of ...

The Rising Wave of Esoteric Testing The Esoteric Testing Market represents a specialized segment of diagnostic laboratory services that focuses on rare and complex tests not routinely performed in ...